Arbutus Biopharma Corp Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Arbutus Biopharma Corp (ABUS) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $188.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2019-11-06
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $188.00K.
- 2019-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $433.00K.
- 2019-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $745.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $188.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $433.00K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $745.00K 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |